Documents detail efforts by White House officials to distribute hydroxychloroquine to coronavirus patients in ‘hard hit’ cities
The phone call in March from President Trump’s adviser carried an urgent message.
For days Trump had touted the off-label use of the anti-malarial drug hydroxychloroquine as a potential cure for covid-19, despite a lack of scientific evidence it worked and amid mounting concerns about the dangers to patients with underlying medical conditions.
Trump trade adviser Peter Navarro wanted to make sure the administration’s top vaccine expert would be on board with a White House plan to distribute the unproven drug to hard-hit cities. Continue reading.